AORTF News Alert Aortech Internationa (AORTF) 0.5000 10/01/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Aortech Internationa (AORTF) 0.5000 $AORTF

Cardiovascular Devices - Europe Pipeline Product Analysis - Stage, Indication And Estimated Approval Date
M2 - Mon Jun 16, 6:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xdmzk9/cardiovascular) has announced the addition of the "Cardiovascular Devices - Europe Pipeline Product Analysis - Stage, Indication And Estimated Approval Date" report to their offering. This report consists of the entire process involved in making of a Cardiovascular Device. Right from Early Development stage through Pre-Clinical to Clinical trails and the Approval Process is also covered in this report. This report includes a total of 91 companies with 182 products in development. This report provides Pipeline Analysis of Cardiovascular devices developed by several medical device companies located in Europe. This report includes a detailed company profile for each medical device company operating in Europe. The company profile includes key company facts, information on business description, mission statement and its location. Moreover, this report provides detailed analysis of all pipeline products of each company with information on the product category, indication, development stage, estimated approval date and pipeline territory of the product. Cardiovascular Device areas covered in this report include: - Cardiac Assist Devices - Cardiovascular Monitoring and Diagnostic Devices - Cardiac Rhythm Management Devices - Cardiovascular Surgery Devices - Electrophysiology Devices - Interventional Cardiology Devices - Peripheral Vascular Devices Transcatheter Heart Valves Why buy the report? - Develop strategies for market entry and expansion. - Identify your competition's product portfolio and create effective strategies to gain competitive advantage. - Design and develop business strategies by understanding current trends and developments. - Identify the status and estimated approval of your competitor's pipeline products and develop your business strategies. Companies Mentioned: - AFreeze GmbH - AVIDAL Vascular GmbH - Aachen Resonance GmbH - Acarix A/S - Acrostak (Schweiz) AG - Aeon Scientific AG - Andramed GmbH - Anethon - AorTech International plc - Arterion AB - Arterius Ltd - B. Braun Melsungen AG - Bayer HealthCare AG - Berlin Heart GmbH - ICON plc - IRAMED GmbH - Imaxdi - Imaxdi. - Impulse Dynamics N.V. - Inserm Transfert SA - International Biomedical Systems S.p.A. - JenaValve Technology GmbH - Leman Cardiovascular - Leukocare AG - MaRVis Technologies GmbH - Maestro Heart SA - Microstim GmbH - iVascular S.L. - iiTech BV For more information visit http://www.researchandmarkets.com/research/xd...iovascular

Cardiovascular Devices - Europe Clinicals Pipeline Product Analysis
M2 - Mon Jun 16, 6:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bbc87m/cardiovascular) has announced the addition of the "Cardiovascular Devices - Europe Clinicals Pipeline Product Analysis" report to their offering. This report provides Pipeline Analysis of Clinical Cardiovascular devices developed by several medical device companies located in Europe. This report includes a total of 52 companies with 120 products in development. This report includes a detailed company profile for each medical device company operating in Europe. The company profile includes key company facts, information on business description, mission statement and its location. Moreover, this report provides detailed analysis on all pipeline products of each company with information on the product category, indication, development stage, estimated approval date and pipeline territory of the product. Cardiovascular Device areas covered in this report include: - Cardiac Assist Devices - Cardiovascular Monitoring and Diagnostic Devices - Cardiac Rhythm Management Devices - Cardiovascular Surgery Devices - Electrophysiology Devices - Interventional Cardiology Devices - Peripheral Vascular Devices - Transcatheter Heart Valves This report is built using data and information from in-house analysis by the team of industry experts at Mordor Intelligence and from primary & secondary research. Why buy the report? - Develop strategies for market entry and expansion. - Identify your competition's product portfolio and create effective strategies to gain competitive advantage. - Design and develop business strategies by understanding current trends and developments. - Identify the status and estimated approval of your competitor's pipeline products and develop your business strategies. Companies Mentioned: - AFreeze GmbH - AVIDAL Vascular GmbH - Aachen Resonance GmbH - Acrostak (Schweiz) AG - Andramed GmbH - AorTech International plc - Arterion AB - B. Braun Melsungen AG - Carmat SAS - CellProthera - Dipylon Medical AB - Eurocor GmbH - Evasc Medical Systems - HighLife SAS - I.B.S. S.p.A. - ICON plc - Imaxdi. - Impulse Dynamics N.V. - Qvanteq AG - SAS Cormove - Sorin S.p.A. - Stentys, S.A - Symetis AG - Tioga Ltd - Tissue Regenix Ltd - Transcatheter Technologies GmbH - TrusTECH For more information visit http://www.researchandmarkets.com/research/bb...iovascular

Transcatheter Heart Valve Market Outlook, 2013
M2 - Mon Jun 10, 3:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3w68nx/transcatheter) has announced the addition of the "Transcatheter Heart Valve Market Outlook, 2013 - Approval of Second Generation Prosthetics and Increasing Surgeons' Confidence and Proficiency to Drive TAVR Procedure Volumes" report to their offering. Newcomer US to Dominate Global Transcatheter Heart Valve Market by 2017 Despite only entering the market in late 2011 with Edwards Lifesciences' Sapien, the US looks set to dominate the global Transcatheter Heart Valve (THV) market in the near future, according to business intelligence provider GBI Research. The firm's latest report* forecasts the number of Transcatheter Aortic Valve Replacement (TAVR) procedures in the US to climb from 7,946 in 2012 to 59,000 in 2017, driving the country's THV market from $238m to $1.9 billion during the same period. GBI Research states that, within one year, the US has managed to become the biggest country for THV sales, accounting for 28% of the glo

MediPoint: Transcatheter Aortic Valve Replacement - Analysis and Market Forecast - European Markets
M2 - Mon Mar 11, 5:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8kfr86/medipoint) has announced the addition of GlobalData's new report "MediPoint: Transcatheter Aortic Valve Replacement - Analysis and Market Forecast - European Markets" to their offering. This report is a vital source of up-to-date information with in-depth analysis on the rapidly growing Transcatheter Aortic Valve Replacement (TAVR) Device Market in France, Germany, Italy, Spain and the UK (EU). Provided within is a comprehensive breakdown of opportunities and inhibitors within the major EU TAVR markets, highlighting testimonials from top physicians from around the world utilizing this technique already. The report identifies and analyzes the key trends shaping and driving the EU Transcatheter Aortic Valve Replacement Market. Future EU sales expectations are discussed through careful analysis of the Transcatheter Aortic Valve Replacement procedure adoption patterns. The report provides insight into the competitive TAVR landscape in the

MediPoint: Transcatheter Aortic Valve Replacement - Analysis and Market Forecast - US Market
M2 - Mon Mar 11, 5:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/brtjc6/medipoint) has announced the addition of GlobalData's new report "MediPoint: Transcatheter Aortic Valve Replacement - Analysis and Market Forecast - US Market" to their offering. This report is a vital source of up-to-date information with in-depth analysis on the rapidly growing Transcatheter Aortic Valve Replacement (TAVR) Device Market in the US. Provided within is a comprehensive breakdown of opportunities and inhibitors within the US TAVR market, highlighting testimonials from top physicians from around the world utilizing this technique already. The report identifies and analyzes the key trends shaping and driving the US Transcatheter Aortic Valve Replacement market. Future US sales expectations are discussed through careful analysis of the Transcatheter Aortic Valve Replacement procedure adoption patterns. The report provides insight into the competitive TAVR landscape in the US, including new companies entering the market and p

MediPoint: Transcatheter Aortic Valve Replacement - Current and Future Players
M2 - Thu Mar 07, 5:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/7vv95q/medipoint) has announced the addition of GlobalData's new report "MediPoint: Transcatheter Aortic Valve Replacement - Current and Future Players" to their offering. This report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Transcatheter Aortic Valve Replacement (TAVR) Device Market. The report identifies and analyses the key companies shaping and driving the global Transcatheter Aortic Valve Replacement market. The report provides insight into the competitive TAVR landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by a team of industry experts. Scope - Investigation of current and future market competition for Transcatheter Aortic Valve Replacement, otherwise known as Transcatheter Aortic Valve Implantatio

MediPoint: Transcatheter Aortic Valve Replacement - Analysis and Market Forecast
M2 - Mon Feb 04, 8:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/94t355/medipoint) has announced the addition of GlobalData's new report "MediPoint: Transcatheter Aortic Valve Replacement - Analysis and Market Forecast" to their offering. New Aortic Valve Devices May Hold the Key to Your Heart Open heart surgery may be a dying art, as new valve replacement techniques offer life-changing treatment without the need for invasive procedures, states a new report by healthcare experts The authors. The new report* studies Transcatheter Aortic Valve Replacement (TAVR), which allows the percutaneous treatment of severe Aortic Valve Disease (AVD) through the implantation of a prosthetic aortic valve within the diseased native valve without the need for open heart surgery or cardiopulmonary bypass. Rob Littlefield, MSc., The authors's analyst for cardiovascular devices, states: "AVD affects over 3.6% of the population older than 65, and severe cases of it have mortality rates of nearly 50% at two years. However,




Scroll down for more posts ▼

Top 10 Most Recent News Articles

SteriLance Aims for Smoother Pricks with NanoSense Move

Updated Category News Views 92

Revamping the Lancing Game Out there in Suzhou, SteriLance Medical is steering clear of just chasing meter accuracy—do enough folks even care about glorified electronics?—they're zeroing in on the needle part of the blood glucose test, the part that pricks your finger every damn day. Yep, this new initiative is inviting blood glucose monitoring (BGM) brands to embrace...

Continue Reading
Ridgeline’s Dome Roof Award Signals Durable Craft Demand

Updated Category News Views 11

A faceted dome in the Alabama woods is about as far from a cookie-cutter reroof as it gets. Ridgeline Roofing & Restoration’s 2026 Excellence Award from Brava Roof Tile matters because the job in Pell City demanded the sort of painstaking field execution that separates a capable contractor from a crew merely moving shingles fast. Geometry Is Where Easy Claims Go to Die...

Continue Reading
Halff Elevates People and Delivery Leadership Team

Updated Category News Views 43

Infrastructure outfits rarely make much noise when they reshuffle leadership, but Halff’s Nov. 18 announcement deserves a closer look than the usual executive-title confetti. The employee-owned consulting firm has put Greg Carpenter in the chief people officer seat and named Leigh Hollis chief delivery officer. One role is aimed squarely at the human machinery; the...

Continue Reading
Fall Pest Risks Linger as Mild Weather Extends Threat

Updated Category News Views 16

A cold snap is not a magic off switch for mosquitoes, ticks, or rodents, and that is the sober point behind the National Pest Management Association's fall and winter 2026 Public Health Pest Index. The group is flagging conditions, not predicting that every household in a named city will face an infestation or illness. Still, mild temperatures, rain, flooding, and plenty...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 234

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
Polsen Flex Deal Puts Pre-Tax Funds Behind Wearables

Updated Category News Views 114

A pile of soon-to-expire FSA cash is a peculiar sales catalyst, but Polsen Health has found one. The Amsterdam-based preventative-health wearable company is partnering with Flex to let customers pay for every Polsen watch and strap using eligible HSA or FSA funds at checkout. No reimbursement chase, no claim forms, and buyers can split the cost with another card. For a...

Continue Reading
Microsoft-Intel Azure Pact Puts Systems Work First

Updated Category News Views 18

Azure’s next bottleneck may be the plumbing between chips, not the chips alone. Microsoft and Intel announced on Nov. 18, 2026, a long-term expansion of their already ancient partnership aimed at shaping select pieces of Azure infrastructure for cloud and AI demand. That sounds dry, because infrastructure announcements usually do. But this one deserves a closer look: it...

Continue Reading
A €18 Million Mecca Chandelier Tests Austrian Craft

Updated Category News Views 134

Scale Is Easy to Boast About, Delivery Is Not A 34.1-metre chandelier hanging in Mecca is the sort of job that makes ordinary project talk sound downright silly. Lights of Vienna says it designed, built, tested, shipped and installed this monster for the Grand Mosque's Shamiya area, with a contract value of roughly €18 million. That is a serious piece of work for a...

Continue Reading
Redseer's $5M Bet on Faster MENA Decision Intelligence

Updated Category News Views 65

Speed has become the expensive commodity in Middle Eastern commerce, and Redseer is putting roughly $5 million behind the idea that executives will pay to get it. Its newly launched Benchmarks MENA 2.0 platform combines proprietary market data with strategic advisory across nine MENA markets. That sounds like another corporate dashboard pitch until you consider the target...

Continue Reading
ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 180

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading

Top 5 Most Recently Viewed Articles

Symbotic Inc. Faces Legal Challenges Amid Financial Irregularities

Updated Category News Views 138

Symbotic Inc. Under Investigation for Securities Violations There has been a significant development for investors of Symbotic Inc. As concerns about the Company’s financial practices have arisen, the Schall Law Firm has initiated an investigation. This effort is aimed at ensuring shareholders are informed and protected amid allegations of misleading statements related...

Continue Reading
Turning Point Brands: Growth Opportunities Ahead with New Rating

Updated Category News Views 103

Turning Point Brands Gets a Positive Buy Rating Recently, Turning Point Brands (NYSE: TPB) earned a favorable Buy rating from Roth/MKM, along with a price target set at $50. This company is known for its wide range of consumer brands in the nicotine, tobacco, and cannabis markets, particularly recognized for its popular rolling papers and moist snuff products. Growth in...

Continue Reading
NeuroSense Therapeutics Celebrates Key Manufacturing Milestone

Updated Category News Views 232

NeuroSense Therapeutics Achieves Commercial Manufacturing Scale-Up NeuroSense Therapeutics Ltd. (NASDAQ: NRSN), a pioneering biotechnology firm dedicated to developing innovative treatments for severe neurodegenerative diseases, has announced a major milestone in its commercial journey. The company has successfully scaled up its production of PrimeC, preparing for...

Continue Reading
Discover the Potential of Azapeptides in Peptide Stability

Updated Category News Views 179

Unveiling the Future of Peptide Stability with Azapeptide Synthesis In this informative webinar, participants will discover how strategies involving azapeptides can significantly enhance the stability of peptides and improve workflows related to synthesis. Attendees will delve into techniques for incorporating aza-amino acids within peptides that utilize traditional amino...

Continue Reading
Ascent Solar Technologies Faces Major Challenges in Market

Updated Category News Views 118

Ascent Solar Technologies Hits 52-Week Low Ascent Solar Technologies, recognized for its cutting-edge thin-film photovoltaic modules, is currently going through a challenging period. The company's stock has reached a 52-week low of $2.32, reflecting an astonishing nearly 99.6% decline over the past year. This drastic drop underscores the significant hurdles the company...

Continue Reading